Replies to post #1267 on Antares Pharma, Inc. (ATRS)

[Mbus57]

I find it interesting that Pfizer has an oral rheumatoid-arthritis drug,Xeljanz.Analyst are predicting one billion in sales.

[Bsav88atty]

UNIS has been a great disappointment. The CEO is a snake oil salesman who has made promise after promise of sales but has completely failed to deliver. ATRS, on the other hand, has taken the opposite approach. I have talked to Jack about UNIS; he believes their technology is substandard. Of course, Jack is bias, but UNIS's lack of sales corroborates Jack's opinion. The one good thing that I can personally say about UNIS, is that it was the UNIS YMB board that led me to AIS in late 2011. UNIS may eventually be successful, but it must take on more debt and issue more secondaries along the way. With ATRS, however, I doubt we see more dilution and we are very close to net positive and the ultimate lift off to substantial hockey stick appreciation in the PPS.